RECENT NEWS
Biomass Magazine  2 hrs ago  Comment 
Solvay has opened in Brazil its first fully dedicated Industrial Biotechnology Laboratory to boost the development of innovations and solutions based on sustainable chemistry, used in a growing range of end-markets.
Forbes  8 hrs ago  Comment 
1)   Which of the following terms in a press release headline means that a clinical trial failed to meet its endpoint? Promising Potential breakthrough Meaningful Suggests All of the above
FierceBiotech  9 hrs ago  Comment 
NuCana is set to start a Phase III trial of Acelarin in patients with pancreatic cancerthis month, kicking off a surge into late-stage studies that will see it work on ovarian and biliary programs later this year. The Sofinnova Ventures-backed...
FierceBiotech  9 hrs ago  Comment 
Anyone looking for an example of just how easy it is to start a biotech buyout rumor these days need look no further than Bloomberg's report on AstraZeneca's Pascal Soriot earlier in the week.
FierceBiotech  11 hrs ago  Comment 
The Biotech 3.0 vision is what we'll be exploring at my upcoming executive breakfast during BIO's annual conference in Philadelphia.
Market Intelligence Center  11 hrs ago  Comment 
After Wednesday's trading in iShares Nasdaq Biotechnology (IBB) MarketIntelligenceCenter.com's patented algorithms uncovered a trade that offers a 4.89% return or 16.83% on an annualized basis (for comparison purposes only), while providing 5.92%...
TheStreet.com  11 hrs ago  Comment 
BOSTON ( TheStreet) -- Oncothyreon was the runaway stock-performance winner of ASCO '15. Between May 12 and June 3, Oncothyreon's stock price rose 183%, best among all the companies presenting cancer drug research at the American Society...
FierceBiotech  Jun 3  Comment 
Two years after Celgene dangled a selection of $225 million milestone prizes in front of bluebird bio in exchange for collaborating on a range of CAR-T cancer drug programs, the Big Biotech has narrowed its sights to a single target and chipped in...




RELATED WIKI ARTICLES

Related Articles

 
TOP CONTRIBUTORS

Biotechnology is the use of molecular biology and genetic engineering techniques to develop treatments for human diseases. Many leading companies from the industry originated in the late 70's from university research laboratories. In the 1980s after attracting venture investors and after listed in the US stock exchange,have then developed into a growing industry that uses research innovations to develop new agricultural products, biomedical tools, and human therapies such as monoclonal antibody for cancer. In 2006, 92% of employees in the biotechnology industry worked in companies that specialized in developing new drugs or medical devices and equipment, while 8% were employed in companies that specialized in agricultural products. [1] The large cap company in the group is Amgen, Genentech, Biogen-Idec, Genzyme. iShares Nasdaq Biotechnology (IBB) offers a low risk/reward investment vehicle for long term investors




Industry Information

Major Biotechnology Companies

ISTA Pharmaceuticals (ISTA)

Biotechnology Industry Trends & Forces

High Pipeline Risk for New Drugs

Dependence on Health Insurance/Medicare Coverage

Dependence on Governmental Regulations

High Volatility and Instability at Start-up

Litigation Risk

Market Share

References

  1. State Bioscience Initiatives 2008 Report, published by the Biotechnology Industry Organization

Top Ten/Twenty Best Selling Drugs 2009 http://knol.google.com/k/top-ten-twenty-best-selling-drugs-2009#

M&A Biotechnology http://knol.google.com/k/m-a-biotechnology#

http://knol.google.com/k/biotechnology-market-review-top-ten-biologics-2009#

Monoclonal Antibody Market 2009 http://knol.google.com/k/-/monoclonal-antibody-market-2009/3fy5eowy8suq3/86#

http://knol.google.com/k/new-drug-approvals-usa-fda-2009#

http://knol.google.com/k/new-drug-approvals-europe-ema-2009#

Vaccine Market 2009 http://knol.google.com/k/-/vaccine-market-2009/3fy5eowy8suq3/104#

Global Monoclonal Antibodies Market Review 2008 (World Top Ten mAbs) http://knol.google.com/k/global-monoclonal-antibodies-market-review-2008-world-top-ten-mabs#

M&A Review: Pharmaceutical & Biotechnology Industry http://knol.google.com/k/m-a-review-pharmaceutical-biotechnology-industry#

Global Vaccine Market Review 2008 (World Top Ten Vaccines) http://knol.google.com/k/global-vaccine-market-review-2008-world-top-ten-vaccines#


Ipilimumab (BMS) Review: A Cancer Breakthrough? http://knol.google.com/k/-/ipilimumab-bms-review-a-cancer/3fy5eowy8suq3/107#

Denosumab (Prolia, Amgen) FDA Review & Approval http://knol.google.com/k/-/denosumab-prolia-amgen-fda-review/3fy5eowy8suq3/60#

Companies in the Biotechnology Industry (193)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki